Essity AB (ESSITY-B.ST) is a leading global hygiene and health company with a portfolio of strong brands in tissue, personal care, and incontinence products. The company is undergoing a significant margin improvement program, with EBITDA margins expanding from 14.5% in 2023 to a projected 17%+ by 2025, driven by cost savings and premiumization. Additionally, Essity benefits from secular growth in emerging markets, where rising hygiene awareness and increasing disposable incomes drive demand. The stock trades at a forward P/E of ~18x, a discount to peers like Kimberly-Clark and Procter & Gamble, offering a re-rating catalyst as margins improve. With a strong balance sheet (net debt/EBITDA ~1.5x) and a dividend yield of ~3%, Essity provides a balanced risk-reward profile.
12-Month Catalysts:
- Margin expansion from cost savings and mix improvement, targeting 17%+ EBITDA margin by 2025.
- Emerging market growth, particularly in Latin America and Asia, driving volume and revenue acceleration.
- Potential portfolio optimization, including divestiture of non-core assets, unlocking shareholder value.
Key Risks:
- Raw material cost inflation (pulp and energy) could pressure margins if not passed through.
- Intense competition in mature markets (Europe, North America) may limit market share gains.
Disclaimer: This is not financial advice. Investing involves risk, including loss of principal. Please conduct your own research or consult a financial advisor.